EP 3787624 A4 20220330 - CAPSULE-IN-CAPSULE COMPOSITIONS OF DABIGATRAN ETEXILATE
Title (en)
CAPSULE-IN-CAPSULE COMPOSITIONS OF DABIGATRAN ETEXILATE
Title (de)
KAPSEL-IN-KAPSEL-ZUSAMMENSETZUNGEN VON DABIGATRAN-ETEXILAT
Title (fr)
COMPOSITIONS CAPSULE DANS CAPSULE D'ÉTÉXILATE DE DABIGATRAN
Publication
Application
Priority
- TR 201806309 A 20180504
- TR 2019050292 W 20190503
- TR 201906582 A 20190503
Abstract (en)
[origin: WO2020032885A2] The present invention relates to capsule-in-capsule compositions comprising dabigatran etexilate in the form of the free base or in the form of pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters thereof and at least one organic acid, characterized in that one of the capsules comprises at least one coating.
IPC 8 full level
A61K 9/48 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/50 (2006.01); A61K 31/4439 (2006.01)
CPC (source: EP)
A61K 9/4808 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/4891 (2013.01); A61K 31/4439 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1652 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/501 (2013.01); A61K 9/5015 (2013.01); A61K 9/5031 (2013.01); A61K 9/5047 (2013.01)
Citation (search report)
- [A] WO 2016142821 A2 20160915 - ALPHAMED FORMULATIONS PVT LTD [IN], et al
- [A] CN 104095830 A 20141015 - AVENTIS PHARMA HAINAN CO LTD
- [A] CN 105560206 A 20160511 - CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD, et al
- [A] CN 104784147 A 20150722 - CHENGDU EASTON PHARMACEUTICAL
- [A] WO 2012001156 A2 20120105 - KRKA TOVARNA ZDRAVIL D D NOVO MESTO [SI], et al
- [A] EP 2929884 A1 20151014 - SANOVEL ILAC SANAYI VE TICARET AS [TR]
- [A] WO 2014152338 A1 20140925 - KABADI MOHAN [US], et al
- [A] WO 0207710 A2 20020131 - MW ENCAP LTD [GB], et al
- [I] DATABASE WPI Section Ch Week 201675, Derwent World Patents Index; Class A96, AN 2016-637397, XP002789451, BALANAGU H B; BALEBOINA S; BEJAWADA S; CHERUVU R; HILL L A: "Capsule dosage form of direct thrombin inhibitor, useful e.g. for treating deep venous thrombosis and pulmonary embolism, and for reducing risk of stroke and systemic embolism, comprises two types of solid unit dosage forms"
- See references of WO 2020032885A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020032885 A2 20200213; WO 2020032885 A3 20200924; EP 3787624 A2 20210310; EP 3787624 A4 20220330
DOCDB simple family (application)
TR 2019050292 W 20190503;